Cargando…
Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways
Clinical success of chimeric antigen receptor (CAR) T cell immunotherapy requires the engineering of autologous T cells, which limits the broader implementation of CAR cell therapy. The development of allogeneic and universal cell products will significantly broaden their application and reduce cost...
Autores principales: | Yang, Yan, Badeti, Saiaditya, Tseng, Hsiang-chi, Ma, Minh Tuyet, Liu, Ting, Jiang, Jie-Gen, Liu, Chen, Liu, Dongfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364029/ https://www.ncbi.nlm.nih.gov/pubmed/32695845 http://dx.doi.org/10.1016/j.omtm.2020.06.014 |
Ejemplares similares
-
CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro
por: Ma, Minh Tuyet, et al.
Publicado: (2021) -
Development of a Novel Human CD147 Transgenic NSG Mouse Model to test SARS-CoV-2 Infection and Immune Responses
por: Badeti, Saiaditya, et al.
Publicado: (2021) -
The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
por: Liu, Dongfang, et al.
Publicado: (2020) -
A Soluble NK-CAR Mediates the Specific Cytotoxicity of NK Cells toward the Target CD20(+) Lymphoma Cells
por: Liu, Rongjiao, et al.
Publicado: (2022) -
Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
por: Heipertz, Erica L., et al.
Publicado: (2021)